ESMO Clinical Practice Guidelines 1
29 Sep 2019
- Introduction - George Pentheroudakis
- Stage III ovarian cancer, BRCA wild type germline and somatic, platinum-sensitive relapse and molecular profiling-Irina Tsibulak
- Discussion-Mansoor Raza Mirza
- Metastatic NSCLC: Immunotherapy-Roberto Ferrara
- Discussion-Noemi Reguart
- Metastatic renal cancer-Ricardo Pereira Mestre
- Discussion-Thomas Powles
- Stage III colorectal cancer: Duration of therapy, molecular profiling-George Zarkavelis
- Discussion-Guillem Argiles
ESMO Clinical Practice Guidelines 2
29 Sep 2019
- Introduction-George Pentheroudakis
- Localised melanoma resected: Adjuvant therapy followed by systemic relapse-Rebecca Lee
- Discussion-Olivier Michielin
- Fatigue in cancer-Juliane Brandt
- Discussion-Fausto Roila
- Advanced hepatoma: Sequence of therapies-Daire Hanna
- Discussion-Arndt Vogel
- Urothelial cancer: Bladder-preserving strategies followed by systemic relapse-Bernadett Szabados
- Discussion-Shahrokh F. Shariat